Controlled Synthesis of CdClOH Sub-nanocones by Low-temperature Solution Process and Their Transformation into CdS Hollow Sub-nanocones

Novel CdClOH sub‐nanocone crystals were successfully synthesized on a large scale by a facile solution‐based method using polymers as crystal growth modifiers. The crystals showed cone‐like morphology. Some factors affecting the morphology and size of the product, such as reaction temperature, concentrations of polyacrylamide (PAM), and pH value of the solution, were systematically studied. Experiments implied that polymer PAM played a key role in the formation of CdClOH sub‐nanocones. A possible formation mechanism of CdClOH sub‐nanocones was suggested based on nucleation‐etching process‐recrystallization in a mild aqueous solution. Furthermore, the as‐prepared CdClOH sub‐nanocones could be further transformed into CdS hollow sub‐nanocones by an anion‐exchange reaction.     

Synthesis,self‐assembly and drug‐loading capacity of well‐defined drug‐conjugated amphiphilic A2B2 type miktoarm star copolymers based on poly(ε‐caprolactone) and poly(ethylene glycol)

Well‐defined drug‐conjugated amphiphilic A₂B₂ miktoarm star copolymers [(PCL)₂‐(PEG)₂‐D] were prepared by the combination of controlled ring‐opening polymerization (CROP) and “click” reaction strategy. First, bromide functionalized poly(ε‐caprolactone) (PCL‐Br) with double hydroxyl end groups was synthesized by the CROP of ε‐caprolactone using 2,2‐bis(bromomethyl)propane‐1,3‐diol as a difunctional initiator in the presence of Sn(Oct)₂ at 110 °C. Next, the bromide groups of PCL‐Br were quantitatively converted to azide form by NaN₃ to give PCL‐N₃. Subsequently, the end hydroxyl groups of PCL‐N₃ were capped with ibuprofen as a model drug at room temperature. Finally, copper(I)‐catalyzed cycloaddition reaction between ibuprofen‐conjugated PCL‐N₃ and slightly excess alkyne‐terminated poly(ethylene glycol) (A‐PEG) led to ibuprofen‐conjugated A₂B₂ miktoarm star copolymer [(PCL)₂‐(PEG)₂‐D]. The excess A‐PEG was removed by dialysis. ¹H NMR, FTIR and SEC analyzes confirmed the expected miktoarm star architecture. These amphiphilic miktoarm star copolymers could self‐assemble into multimorphological aggregates in aqueous solution, which were characterized by dynamic light scattering (DLS) and transmission electron microscopy (TEM). In addition, the drug‐loading capacity of these drug‐conjugated miktoarm star copolymers as well as their nondrug‐conjugated analogs were also investigated in detail. © 2009 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem, 2009     

Efficient two-dimensional atom localization in a five-level conductive chiral atomic medium via birefringence beam absorption spectrum

We have theoretically investigated two-dimensional atom localization using the absorption spectra of birefringence beams of light in a single wavelength domain.The atom localization is controlled and modified through tunneling effect in a conductive chiral atomic medium with absorption spectra of birefringent beams.The significant localization peaks are investigated in the left and right circularly polarized beam.Single and double localized peaks are observed in different quadrants with minimum uncertainty and significant probability.The localized probability is modified by controlling birefringence and tunneling conditions.These results may be useful for the capability of optical microscopy and atom imaging.     

High Loading Efficiency and Controlled Release of Bioactive Immunotherapeutic Proteins Using Vaterite Nanoparticles

Nanoparticles may limit off-tumor/on-target ubiquitous activation of signaling by protein-based drugs. However, many challenges still exist in the design of a nanoparticle for protein delivery. In this study, conditions to establish vaterite nanoparticles as a pH-sensitive drug delivery system (DDS) for encapsulated protein drugs are comprehensively evaluated. Low coprecipitation pH of vaterite and protein prevents protein denaturation and yields high loading efficiency. Unprotected vaterite recrystallizes in aqueous solutions within 3 h to calcite and releases the loaded protein completely, but surface-modified particles with carboxyl groups containing polymers prove stable for more than 5 months. Notably, modification of vaterite with sulfonated polymers increases the loading of cationic proteins by a multiple. A system is developed for vaterite exposure to (pH) conditions under body-like-flow rates, with the dissolution of vaterite and simultaneous release of active proteins at tumor microenvironmental pH reaching up to 80% and only 20% at physiological pH within 2 h. Importantly, the immunomodulatory protein tumor necrosis factor preserves its native structure and fully retains functional activity in vitro after release from the particles. In conclusion, the studies described here provide a framework for the development of vaterite-based DDS as a carrier for bioactive protein-based therapeutics.     

Atomically flat single terminated oxide substrate surfaces

Scientific interest in atomically controlled layer-by-layer fabrication of transition metal oxide thin films and heterostructures has increased intensely in recent decades for basic physics reasons as well as for technological applications. This trend has to do, in part, with the coming post-Moore era, and functional oxide electronics could be regarded as a viable alternative for the current semiconductor electronics. Furthermore, the interface of transition metal oxides is exposing many new emergent phenomena and is increasingly becoming a playground for testing new ideas in condensed matter physics. To achieve high quality epitaxial thin films and heterostructures of transition metal oxides with atomically controlled interfaces, one critical requirement is the use of atomically flat single terminated oxide substrates since the atomic arrangements and the reaction chemistry of the topmost surface layer of substrates determine the growth and consequent properties of the overlying films. Achieving the atomically flat and chemically single terminated surface state of commercially available substrates, however, requires judicious efforts because the surface of as-received substrates is of chemically mixed nature and also often polar. In this review, we summarize the surface treatment procedures to accomplish atomically flat surfaces with single terminating layer for various metal oxide substrates. We particularly focus on the substrates with lattice constant ranging from 4.00 Å to 3.70 Å, as the lattice constant of most perovskite materials falls into this range. For materials outside the range, one can utilize the substrates to induce compressive or tensile strain on the films and explore new states not available in bulk. The substrates covered in this review, which have been chosen with commercial availability and, most importantly, experimental practicality as a criterion, are KTaO₃, REScO₃ (RE = Rare-earth elements), SrTiO₃, La_0.18Sr_0.82Al_0.59Ta_0.41O₃ (LSAT), NdGaO₃, LaAlO₃, SrLaAlO₄, and YAlO₃. Analyzing all the established procedures, we conclude that atomically flat surfaces with selective A- or B-site single termination would be obtained for most commercially available oxide substrates. We further note that this topmost surface layer selectivity would provide an additional degree of freedom in searching for unforeseen emergent phenomena and functional applications in epitaxial oxide thin films and heterostructures with atomically controlled interfaces.     

以混合表面活性剂为模板可控合成MCM-48和MCM-41分子筛

利用阳离子和三嵌段共聚物混合表面活性剂为模板,在水热条件、碱性介质中可控合成出MCM-48和MCM-41分子筛。在固定P123(聚氧乙烯-聚氧丙烯-聚氧乙烯三嵌段共聚物):TEOS(正硅酸乙酯)(物质的量的比)为0.01875的体系中,调节CTAB(十六烷基三甲基溴化铵)∶TEOS(正硅酸乙酯)物质的量比值m,当m在0.12~0.13范围合成出MCM-48分子筛;当m在0.04~0.08范围合成出MCM-41分子筛。通过XRD,TEM,N2物理吸附,IR等方法进行了表征。结果表明:聚氧乙烯-聚氧丙烯-聚氧乙烯三嵌段共聚物(P123)的加入可以更大程度地降低合成介孔材料所需阳离子表面活性剂的用量;可控合成的介孔材料具有高比表面积、高度有序的孔道结构、较集中的孔径分布。     

Ring‐opening metathesis polymerization of fatty acid derived monomers

The ring‐opening metathesis polymerization (ROMP) of fatty acid functionalized norbornenes was explored in the presence of dichloro[1,3‐bis(2,4,6‐trimethylphenyl)‐2‐imidazolidinylidene](benzylidene)bis(3‐bromopyridine)ruthenium(II) ( C3 ) at room temperature. The investigated monomers were derived from fatty acids with different chain lengths (C₆, C₈, C₁₀, C₁₂, C₁₄, C₁₆, and C₁₈) and can therefore contribute to the development of more sustainable, bio‐based polymeric materials. The polymerizations initiated by C3 proceeded in a living fashion with good initiation efficiency, and thus the synthesis of well‐defined polymers with narrow polydispersities was accomplished. All prepared polymers were fully characterized (GPC, DSC, TGA, NMR) and the results of these investigations are discussed within this contribution. © 2010 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem, 2010     

Heteroscedastic controlled calibration model applied to analytical chemistry

In chemical analyses performed by laboratories, one faces the problem of determining the concentration of a chemical element in a sample. In practice, one deals with the problem using the so‐called linear calibration model, which considers that the errors associated with the independent variables are negligible compared with the former variable. In this work, a new linear calibration model is proposed assuming that the independent variables are subject to heteroscedastic measurement errors. A simulation study is carried out in order to verify some properties of the estimators derived for the new model and it is also considered the usual calibration model to compare it with the new approach. Three applications are considered to verify the performance of the new approach. Copyright © 2010 John Wiley & Sons, Ltd.     

Novel ‘Nano in Nano’ Composites for Sustained Drug Delivery: Biodegradable Nanoparticles Encapsulated into Nanofiber Non‐Wovens

Novel ‘nano in nano’ composites consisting of biodegradable polymer nanoparticles incorporated into polymer nanofibers may efficiently modulate drug delivery. This is shown here using a combination of model compound‐loaded biodegradable nanoparticles encapsulated in electrospun fibers. The dye coumarin 6 is used as model compound for a drug in order to simulate drug release from loaded poly(lactide‐co‐glycolide) nanoparticles. Dye release from the nanoparticles occurs immediately in aqueous solution. Dye‐loaded nanoparticles which are encapsulated by electrospun polymer nanofibers display a significantly retarded release.